[
  {
    "ts": null,
    "headline": "Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients",
    "summary": "Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024. SABCS is the preeminent conference for sharing cutting-edge breast cancer research with healthcare professionals, researchers, and",
    "url": "https://finnhub.io/api/news?id=db320e336a8291c82382c966387e2fdd72af8a25749ba4496138367e743e1b57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732625520,
      "headline": "Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients",
      "id": 131651209,
      "image": "https://media.zenfs.com/en/prnewswire.com/b1f373d44e5121962defb25a6d8fe7e3",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024. SABCS is the preeminent conference for sharing cutting-edge breast cancer research with healthcare professionals, researchers, and",
      "url": "https://finnhub.io/api/news?id=db320e336a8291c82382c966387e2fdd72af8a25749ba4496138367e743e1b57"
    }
  }
]